Some Answers and More Questions About Portal Vein Thrombosis in Patients With Decompensated Cirrhosis
- 1 October 2020
- journal article
- editorial
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (11) , 2432-2434
Abstract
No abstract availableFunding Information
- American Association for the Study of Liver Diseases
- National Institutes of Health
This publication has 16 references indexed in Scilit:
- Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute DecompensationClinical Gastroenterology and Hepatology, 2020
- Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysisTransplant International, 2018
- Long-Term Outcome of Splanchnic Vein Thrombosis in CirrhosisClinical and Translational Gastroenterology, 2018
- Acute-on-Chronic Liver Failure in China: Rationale for Developing a Patient Registry and Baseline CharacteristicsAmerican Journal of Epidemiology, 2018
- Reversal of hypercoagulability in patients with HCV‐related cirrhosis after treatment with direct‐acting antiviralsLiver International, 2018
- Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysisGastroenterology, 2017
- Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal studyHepatology, 2015
- Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced CirrhosisGastroenterology, 2012
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006
- Upper Digestive Bleeding in Cirrhosis. Post–Therapeutic Outcome and Prognostic IndicatorsHepatology, 2003